Adjuvant anthracycline therapy as a prognostic factor in metastatic breast cancer

被引：0
作者：
Emilio Alba
Nuria Ribelles
Isabel Sevilla
Antonio Rueda
Lorenzo Alonso
Antonia Marquez
Inmaculada Ruiz
José Miramón
机构：
[1] Hospital Clínico Universitario,Servicio de Oncología
来源：
Breast Cancer Research and Treatment | 2001年 / 66卷
关键词：
adjuvant therapy; anthracyclines; breast cancer; chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background. Prognostic factors in metastatic breast cancer continue to be identified. Previous adjuvant chemotherapy appeared to have poor prognosis in some studies but, despite this, the prior use of anthracyclines in the adjuvant setting has not been clearly established as an adverse prognostic factor once metastatic disease develops.
引用
收藏
页码：33 / 39
页数：6
相关论文
共 179 条
[1]  
Chlebowsky RT(1998)Tamoxifen for early breast cancer: an overview of the randomised trials Lancet 351 1451-1467
[2]  
Weiner JM(1998)Polychemotherapy for early breast cancer: an overview of the randomised trials Lancet 352 930-942
[3]  
Luce J(1981)Significance of relapse after adjuvant treatment with combination chemotherapy or 5-fluoruracil alone in high risk breast cancer Cancer Res 41 4399-4403
[4]  
Hestorff R(1987)Possible adverse effect of failed adjuvant chemotherapy on the prognosis of women receiving consecutive chemotherapy for recurrent breast cancer J Cancer Res Clin Oncol 113 488-494
[5]  
Lang JE(1988)The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer J Surg Oncol 37 116-122
[6]  
Reynolds R(1989)Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancer Breast Cancer Res Treat 13 135-142
[7]  
Godfrey T(1979)Prognostic factors in metastatic breast cancer treated with combination chemotherapy Cancer Res 39 1552-1562
[8]  
Ryden VM(1989)Diverse prognosis in metastatic breast cancer: Who should be offered alternative initial therapy Breast Cancer Res Treat 13 33-38
[9]  
Bateman JR.(1990)Study of prognostic factors in the response of first line chemotherapy in advanced breast cancer Bull Cancer 77 941-947
[10]  
Dittrich C(1992)Survival after first recurrence of breast cancer Cancer 70 129-135
12345678910